Having both patient advocates and patients at the MDT meeting might be useful

Eigenmann’s recommendation that patients’ advocates attend the multidisciplinary team (MDT) meeting, not patients themselves, is interesting.1 Of those patients with cancer who know what an MDT is, many do not understand why they cannot attend a meeting at which they will be discussed. And many patients do not even understand what an MDT is. When you’re first diagnosed …